IDXX IDEXX Laboratories, Inc.
Healthcare
Price
$591.07
Intrinsic value
$142.45
Buy price
$113.96
Discount
-314.9%
DCF walkthrough
Near-term growth (g1)8.52%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $1,371,510,000.00
- Total debt
- $1,096,081,024.00
- Cash & STI
- $196,932,992.00
- Shares out.
- 79,312,000
Overvalued
Intrinsic value$142.45
Buy price (with MOS)$113.96
Current price$591.07
Discount to intrinsic value-314.9%
7-step quality scorecard
ROE quality
HIGH_DISTORTED- Average ROE
- 72.5%
- Current ROE
- 66.0%
- Minimum ROE
- 55.7%
Debt quality
MODERATE- Debt / Equity
- 0.68x
Moat proxy
MODERATE_PROXYCash-flow reliability
OK- Operating CF / Net income
- 1.20x
Technical chart
Confluence: DOWNTREND (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(revenueCAGR,cfCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 9%
- Public economic interest
- 100.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.